Navigation Links
Identification of genetic markers for ulcerative colitis could lead to treatment
Date:1/8/2009

play a role. Technology developed in recent years has enabled systematic, genome-wide searches for gene markers associated with common human diseases, and the discovery of more than 30 genetic risk factors for Crohn's disease has been one of the major success stories in this new era of research.

While some genetic factors associated with Crohn's disease also predispose individuals to ulcerative colitis, markers specific for ulcerative colitis had yet to be found. To do so, researchers performed a genome-wide association study of hundreds of thousands of genetic markers using DNA samples from 1,052 individuals with ulcerative colitis and pre-existing data from 2,571 controls, all of European ancestry and residing in North America.

Several genetic markers on chromosomes 1p36 and 12q15 showed highly significant associations with ulcerative colitis, and the association evidence was replicated in independent European ancestry samples from North America and southern Italy.

Nearby genes implicated as possibly playing a role in ulcerative colitis include the ring finger protein 186 (RNF186), OTU domain containing 3 (OTUD3), and phospholipase A2, group IIE (PLA2G2E) genes on chromosome 1p36, and the interferon, gamma (IFNG), interleukin 26 (IL26), and interleukin 22 (IL22) genes on chromosome 12q15 that play an important role in inflammation. RNF186 and OTUD3 are members of gene families involved in protein turnover and diverse cellular processes. PLA2G2E, IFNG, IL26 and IL22 are known to play a role in inflammation and the immune response.

The study also found highly suggestive associations between ulcerative colitis and genetic markers on chromosome 7q31 within or near the laminin, beta 1 (LAMB1) gene, which is a member of a gene family known to play a role in intestinal health and disease, and confirmed previously identified associations between ulcerative colitis and genetic variants in the interleukin 23 receptor (IL23R) gene on
'/>"/>

Contact: Julie Chevrette
julie.chevrette@icm-mhi.org
514 376-3330 x

Mon2641
University of Montreal
Source:Eurekalert


Page: 1 2 3

Related medicine news :

1. Community Health Centers Reveal Specific Ramifications of The Medicaid Citizenship and Identification Documentation Requirements
2. Identification of new genes shows a complex path to cell death
3. Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples
4. Isis Announces Approximately $2.8 Million in Government Grants and Contracts Awarded to its Ibis Subsidiary to Advance Ibis Pathogen Identification Technology
5. Body identification by facial reconstruction will cost less time and money
6. Identification of dopamine mother cells could lead to future Parkinsons treatments
7. Worried Your Pet Will Get Lost or Stolen? Invest in Pet Identification
8. Winning Method - Effective Identification and Development of Clinical Investigators
9. Identification of 5 genes involved in the metastasis of breast tumors to the lung
10. The Second International Conference on Signs of Autism in Infants: Changing Outcomes through Early Identification and Intervention, October 11 and 12, 2008. Save the Date!
11. 2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:MIT's McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia 2Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 2Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 3Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 4Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 5Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 6Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 7Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 8Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 9Health News:AmeriHealth Mercy Family of Companies Acquires Community Behavioral HealthCare Network of Pennsylvania 2Health News:Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars 2Health News:AMERIGROUP Foundation Announces Winners of 'Word About Health' Contest 2Health News:MUSC's Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients 2
Breaking Medicine Technology:Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 3Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 4Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 1InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 2InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 3InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 4Cell Therapeutics Inc Announces Closing of Registered Offering of 2430 Million of Preferred Stock and Warrants 13648 1Cell Therapeutics Inc Announces Closing of Registered Offering of 2430 Million of Preferred Stock and Warrants 13648 2DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 1DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 2DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 3DS Waters of America Inc Partners With Susan G Komen for the Cure 28R 29 55050 4